Fascin expression in dendritic cells and tumor epithelium in thymoma and thymic carcinoma

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1025-1032

  Sato, Junichiro ^a   Fujiwara, Masachika ^b   Kawakami, Tomohiro ^d   Sumiishi, Ayumi ^b   Sakata, Seiji ^b   Sakamoto, Atsuhiko ^b   Kurata, Atsushi ^c  

^a KYORIN UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Dendritic cell; Fascin; Immunohistochemistry; Thymoma; Tumor immunity

Indexed keywords

FASCIN;

ADULT; ARTICLE; CANCER STAGING; CARCINOMA; CELL DIFFERENTIATION; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EPITHELIUM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; MYASTHENIA GRAVIS; PROGNOSIS; PROTEIN EXPRESSION; THYMIC CARCINOMA; THYMOMA; TUMOR IMMUNITY;

EID: 80052800570     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.383     Document Type: Article

References (32)

1. Kurup A and Loehrer PJ Sr: Thymoma and thymic carcinoma: therapeutic approaches. Clin Lung Cancer 6: 28-32, 2004.
2. Duwe BV, Sterman DH and Musani AI: Tumors of the mediastinum. Chest 128: 2893-2909, 2005.
3. Marx A, Ströbel P, Zettl A, Chan JKC, Müller-Hermelink HK, Harris NL, Kuo TT, Shimosato Y and Engel P: Thymomas. In: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (WHO classification of tumors series). Travis WD, Brambilla E, Müller-Helmelink HK and Harris CC (eds). IARC Press, Lyon, France, pp152-171, 2004.
4. Margaritora S, Cesario A, Cusumano G, Meacci E, D'Angelillo R, Bonassi S, Carnassale G, Porziella V, Tessitore A, Vita ML, Lauriola L, Evoli A and Granone P: Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg 89: 245-252, 2010.
5. Masaoka A, Monden Y, Nakahara K and Tanioka T: Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485-2492, 1981.
6. Okumura M, Miyoshi S, Takeuchi Y, Yoon HE, Minami M, Takeda SI, Fujii Y, Nakahara K and Matsuda H: Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 117: 605-613, 1999.
7. Gerner MY and Mescher MF: Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells. J Immunol 182: 2726-2737, 2009.
8. Kornstein MJ, Hoxie JA, Levinson AI and Brooks JJ: Immunohistology of human thymomas. Arch Pathol Lab Med 109: 460-463, 1985.
9. Pomplun S, Wotherspoon AC, Shah G, Goldstraw P, Ladas G and Nicholson AG: Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Histopathology 40: 152-158, 2002.
10. Lee D and Wright DH: Immunohistochemical study of 22 cases of thymoma. J Clin Pathol 41: 1297-1304, 1988.
11. Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, Mosialos G and Said JW: Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Am J Pathol 150: 543-562, 1997.
12. Kurata A, Terado Y, Schulz A, Fujioka Y and Franke FE: Inflammatory cells in the formation of tumor-related sarcoid reactions. Hum Pathol 36: 546-554, 2005.
13. Machesky LM and Li A: Fascin: invasive filopodia promoting metastasis. Commun Integr Biol 3: 263-270, 2010.
14. Darnel AD, Behmoaram E, Vollmer RT, Corcos J, Bijian K, Sircar K, Su J, Jiao J, Alaoui-Jamali MA and Bismar TA: Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clin Cancer Res 15: 1376-1383, 2009.
15. Iguchi T, Aishima S, Umeda K, Sanefuji K, Fujita N, Sugimachi K, Gion T, Taketomi A, Maehara Y and Tsuneyoshi M: zFascin expression in progression and prognosis of hepatocellular carcinoma. J Surg Oncol 100: 575-579, 2009.
16. Yildiz L, Kefeli M, Aydin O and Kandemir B: Fascin expression in melanocytic lesions of the skin. Eur J Dermatol 19: 445-450, 2009.
17. Zhang FR, Tao LH, Shen ZY, Lv Z, Xu LY and Li EM: Fascin expression in human embryonic, fetal, and normal adult tissue. J Histochem Cytochem 56: 193-199, 2008.
18. Brunhuber T, Haybaeck J, Schäfer G, Mikuz G, Langhoff E, Saeland S, Lebecque S, Romani N and Obrist P: Immuno-histochemical tracking of an immune response in mammary Paget's disease. Cancer Lett 272: 206-220, 2008.
19. Ozerhan IH, Ersoz N, Onguru O, Ozturk M, Kurt B and Cetiner S: Fascin expression in colorectal carcinomas. Clinics 65: 157-164, 2010.
20. Onodera M, Zen Y, Harada K, Sato Y, Ikeda H, Itatsu K, Sato H, Ohta T, Asaka M and Nakanuma Y: Fascin is involved in tumor necrosis factor-alpha-dependent production of MMP9 in cholangiocarcinoma. Lab Invest 89: 1261-1274, 2009.
21. Xie JJ, Xu LY, Wu JY, Shen ZY, Zhao Q, Du ZP, Lv Z, Gu W, Pan F, Xu XE, Xie D and Li EM: Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am J Pathol 176: 939-951, 2010.
22. Kefeli M, Yildiz L, Kaya FC, Aydin O and Kandemir B: Fascin expression in uterine smooth muscle tumors. Int J Gynecol Pathol 28: 328-333, 2009.
23. Durmaz A, Kurt B, Ongoru O, Karahatay S, Gerek M and Yalcin S: Significance of fascin expression in laryngeal squamous cell carcinoma. J Laryngol Otol 124: 194-198, 2010.
24. Marchevsky AM, Gupta R, McKenna RJ, Wick M, Moran C, Zakowski MF and Suster S: Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 112: 2780-2788, 2008.
25. Kondo K, Mukai K, Sato Y, Matsuno Y, Shimosato Y and Monden Y: An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes. Am J Surg Pathol 14: 1139-1147, 1990.
26. Rouse RV and Weiss LM: Human thymomas: evidence of immunohistologically defined normal and abnormal microenvironmental differentiation. Cell Immunol 111: 94-106, 1988.
27. Kurata A, Terado Y, Izumi M, Fujioka Y and Franke FE: Where does the antigen of cutaneous sarcoidosis come from? J Cutan Pathol 37: 211-221, 2010.
28. Wakimoto T, Tomisaka R, Nishikawa Y, Sato H, Yoshino T and Takahashi K: Identification and characterization of human thymic cortical dendritic macrophages that may act as professional scavengers of apoptotic thymocytes. Immunobiology 213: 837-847, 2008.
29. Ambe K, Mori M and Enjoji M: S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer 63: 496-503, 1989.
30. Becker Y: Anticancer role of dendritic cells (DC) in human and experimental cancers-a review. Anticancer Res 12: 511-520, 1992.
31. Müller-Hermelink HK, Möller P, Engel P, Menestrina F, Kuo TT, Shimosato Y, Ströbel PH, Asamura H, Marx A, Masaoka A, Harris NL and Sobin LH: Tumours of the thymus. In: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (WHO classification of tumors series). Travis WD, Brambilla E, Müller-Helmelink HK and Harris CC (eds). IARC Press, Lyon, France, pp145-151, 2004.
32. Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, LaéM, Louvard D, Ben-Ze'ev A and Robine S: Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67: 6844-6853, 2007.